
GP 1a
CAS No. 511532-96-0
GP 1a( —— )
Catalog No. M35265 CAS No. 511532-96-0
GP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 78 | Get Quote |
![]() ![]() |
5MG | 107 | Get Quote |
![]() ![]() |
10MG | 169 | Get Quote |
![]() ![]() |
25MG | 330 | Get Quote |
![]() ![]() |
50MG | 490 | Get Quote |
![]() ![]() |
100MG | 683 | Get Quote |
![]() ![]() |
500MG | 1377 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGP 1a
-
NoteResearch use only, not for human use.
-
Brief DescriptionGP 1a is a potent agonist of cannabinoid receptor 2 (CB2) (EC50=7.1), as shown in cAMP, GTPγS and β-arrestin recruitment assays.
-
DescriptionGP1a is a potent agonist of cannabinoid receptor 2 (CB2). Gp1a is beneficial to skin wound healing. GP1a inhibits inflammation and fibrogenesis while promoting re-epithelialization.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayGPCR/G Protein
-
TargetCannabinoid Receptor
-
RecptorCannabinoid Receptor | PERK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number511532-96-0
-
Formula Weight441.35
-
Molecular FormulaC23H22Cl2N4O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (283.22 mM; Ultrasonic )
-
SMILESC(NN1CCCCC1)(=O)C=2C3=C(N(N2)C4=C(Cl)C=C(Cl)C=C4)C=5C(C3)=CC(C)=CC5
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhao C, et al. An enzyme-responsive Gp1a-hydrogel for skin wound healing. J Biomater Appl. 2021;36(4):714-721.?
molnova catalog



related products
-
Cannabichromene
Cannabichromene is a major non-psychotropic phytocannabinoid that inhibits endocannabinoid inactivation and activates the transient receptor potential ankyrin-1 (TRPA1).
-
RVD-Hpα
N-terminally extended form of human hemopressin that acts as a selective CB1 receptor agonist. Increases intracellular Ca2+ levels in cells expressing CB1 receptors in vitro. Also high affinity CB2 positive allosteric modulator (Ki = 50 nM).
-
NESS-0327
A potent, selective CB1 cannabinoid receptor antagonist with Ki of 350 fM.